Moxifloxacin Stulln

Moxifloxacin, the active ingredient in Moxifloxacin Stulln, is a fluoroquinolone antibiotic presented as a solution for ocular use. It treats bacterial conjunctivitis and bacterial keratitis in patients requiring topical eye therapy and is indicated for eye infections caused by susceptible bacteria, providing a broad spectrum of activity against Gram‑positive and Gram‑negative ocular pathogens.

GNH USA supplies Moxifloxacin Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory adherence, and reliable global logistics.

Moxifloxacin is a fluoroquinolone antibiotic used to treat bacterial infections of the eye. - Bacterial conjunctivitis: reduces bacterial load and resolves redness, discharge, and irritation. - Bacterial keratitis: eradicates causative organisms and promotes corneal healing. - Post‑operative ocular infection: prevents or treats infection following eye surgery.

Topical ocular moxifloxacin may cause a range of local and systemic adverse reactions.

Common Side Effects: - Eye irritation: transient burning or stinging upon instillation. - Redness: mild conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Corneal ulceration: worsening of corneal lesions. - Allergic reaction: eyelid edema, rash, or anaphylaxis. - Tendon rupture: rare systemic tendon injury.

When using Moxifloxacin Stulln, consider the following safety measures. - Contraindication: known hypersensitivity to moxifloxacin or other fluoroquinolones. - Caution: use with caution in patients with corneal epithelial defects. - Interaction: avoid concurrent use with topical corticosteroids unless prescribed. - Pregnancy: safety not established; avoid unless benefit outweighs risk. - Store below 25°C: keep in original container, protect from light and moisture.

Moxifloxacin may interact with other medicines; monitor patients accordingly.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon toxicity. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, monitor INR.

Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may reduce ocular absorption, separate administration. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of corneal complications. - Corticosteroid eye drops: may mask signs of infection, monitor closely.